蔚蓝生物公告称，2025年12月26日，公司召开第五届董事会第二十二次会议，审议通过2026年度日常关 联交易预计议案，无需提交股东会审议。2025年1 - 11月，公司向北大荒宝泉岭农牧发展有限公司及其 子公司实际销售产品807.95万元，受市场行情影响低于1500万元的预计金额。2026年，公司预计向其销 售酶制剂等产品1500万元，占同类业务比例1.23%。交易定价以市场价格为基础，不会影响公司独立 性。 ...

证券日报网12月24日讯，溢多利（300381）在12月23日回答调研者提问时表示，公司现有的电镀过氧化 氢酶主要用于电子产品生产过程中的清洗环节，帮助去除材料表面附着的过氧化氢，具体应用的产品取 决于生产商的制造工艺。该产品自去年开始销售，随着公司对菌种研发及产品性能持续进行改进，今年 前三季度的销售额和毛利率较去年有所提升，但总体收入占比仍然较小。 ...

记者从工业和信息化部网站了解到，经省级主管部门推荐、专家评价、面向社会公示等程序，首批 生物制造中试能力建设平台名单公布，全国共有43家平台入选。其中山东齐鲁制药有限公司(生物制药 方向）、山东隆科特酶制剂有限公司（酶制剂方向）、山东大学（食品及添加剂、酶制剂方向）入选。 聚焦食品及添加剂、生物制药、化妆品、化工、能源、酶制剂等重点产品领域，工信部提出开展生 物制造中试能力建设平台培育，带动产业链上下游协同创新发展。列入名单的平台需聚焦相应服务领 域，持续加大资源投入力度，强化软硬件建设和专业人才培养，提升平台对外开放和中试服务水平。工 信部将按年度组织专家对列入名单的平台软硬件水平、对外开展中试服务的数量及质效等方面进行评 估，动态调整平台服务能力星级，对服务能力、服务效果达不到要求以及知识产权、安全生产、环境保 护、质量安全等方面出现严重违法违规情况的平台予以除名。（记者 付玉婷） ...

Core Viewpoint - Yidoli is actively enhancing its product offerings in the food enzyme sector through continuous research and development, aiming to improve strain performance and production processes while expanding its competitive edge in the food industry [2] Group 1: Product Offerings - The company’s food enzymes include high-temperature α-amylase, fungal α-amylase, pullulanase, xylanase, and glucose oxidase, which are widely used in industries such as starch sugar, alcohol, beverages, and baking [2] Group 2: Innovation and Market Demand - The company plans to strengthen application research and development in the food industry to launch new products that meet market demands, thereby further enhancing its product competitiveness [2]

Core Insights - The phytic acid enzyme market is experiencing significant growth, primarily driven by increased demand in the feed industry, especially after the ban on antibiotics in animal feed in China in 2020, positioning phytic acid enzymes as ideal alternatives [1][7] - China's annual production of phytic acid enzymes has significantly increased, from 43,200 tons in 2015 to an expected 120,600 tons by 2024, indicating a robust growth trajectory [1][8] - The global phytic acid enzyme market is projected to grow from $513 million in 2023 to $822 million by 2029, with a compound annual growth rate (CAGR) of 8.2% [6] Industry Overview - Phytic acid enzymes belong to the class of phosphoric monoester hydrolases and are crucial for enhancing the bioavailability of minerals in plant-based feeds by breaking down phytic acid [2] - The industry has evolved through three stages: initial development in the 1990s, rapid growth from 2001 to 2012, and a mature phase from 2013 onwards, with domestic products replacing imports and achieving international technical standards [3][4] Industry Chain - The upstream of the phytic acid enzyme industry includes raw materials such as wheat, barley, and microorganisms, while the downstream applications span food, pharmaceutical, and feed industries [5] - The feed industry is the largest application area for phytic acid enzymes, driven by the need to improve feed efficiency and reduce costs, with a notable increase in China's feed production reaching 250.7 million tons in the first nine months of 2025, up 6.4% year-on-year [5][6] Competitive Landscape - The global phytic acid enzyme market is highly competitive, with companies like Novozymes, DuPont, and DSM holding significant market shares due to their technological advantages and patent protections [8] - Chinese companies such as Blue Horizon Biotechnology, Yidali, and Xinghuo Technology are emerging as strong competitors, gradually capturing high-end market segments [8] Development Trends - Technological innovation is a key driver for the industry, with advancements in enzyme production and purification methods expected to enhance yield and efficiency [10] - The application of phytic acid enzymes is expanding beyond traditional uses in poultry and pig feed to include aquaculture and organic agriculture, indicating new growth opportunities [11] - Environmental sustainability is becoming increasingly important, with stricter regulations prompting phytic acid enzyme companies to enhance their eco-friendly practices and production processes [12]

Core Insights - The report focuses on the global market for food and beverage cellulase enzymes, analyzing market size, growth trends, and competitive landscape from 2020 to 2031 [2][3][4]. Market Overview - The global food and beverage cellulase enzyme market is segmented by product type and application, with projections for market size in 2020, 2024, and 2031 [3][4]. - The report highlights the overall development status of the food and beverage cellulase enzyme industry, including key characteristics and influencing factors [3][4]. Competitive Landscape - The report provides market share and rankings of major companies in the food and beverage cellulase enzyme sector based on sales volume and revenue for the years 2022 to 2025 [4][5]. - It includes a detailed analysis of the top five manufacturers' market shares in 2024 and their competitive positioning [5][6]. Regional Analysis - The report analyzes the supply and demand dynamics of food and beverage cellulase enzymes in major global regions, including North America, Europe, China, Japan, Southeast Asia, and India, with forecasts for production and revenue [5][6][7]. - It also examines the market size and growth rates for these regions from 2020 to 2031 [5][6]. Product and Application Segmentation - The report categorizes the food and beverage cellulase enzymes by product type and application, providing insights into sales volume and revenue trends [6][7]. - It forecasts the market share and growth rates for different product types and applications from 2020 to 2031 [6][7]. Industry Trends and Drivers - The report discusses the key trends and driving factors influencing the food and beverage cellulase enzyme industry, including technological advancements and regulatory impacts [8][9]. - It includes a SWOT analysis of Chinese companies in the sector, highlighting strengths, weaknesses, opportunities, and threats [8][9]. Supply Chain Analysis - The report outlines the supply chain dynamics of the food and beverage cellulase enzyme industry, including procurement and production models [9][10]. - It identifies key raw materials and their supply situation, as well as customer analysis across different applications [9][10].

Core Insights - The article discusses the first batch of bio-manufacturing landmark products announced by Hubei Province's Economic and Information Technology Department on October 9, highlighting significant advancements in the bio-manufacturing sector [2]. Group 1: Landmark Products - The first batch of landmark bio-manufacturing products includes: - Dongyang Sunshine: Thiocyanate Erythromycin - Tianji Bioenergy: Ultra-clean biodiesel - Bafeng Pharmaceutical: Amino acid raw materials - Xinhua Yang: Feed enzyme preparations - Guangji Pharmaceutical: High-quality riboflavin - China National Pharmaceutical Group: Inactivated vaccine for Porcine Circovirus Type 2 - Aibotai Bio: Research antibodies - Huisheng Biotechnology: Tylosin tartrate - Hite Bio-pharmaceutical: Injectable Epinephrine - Fuxing Biotechnology: Arachidonic acid (ARA) powder [2][3]. Group 2: Product Categories - The products are categorized into different types: - Scale Replacement Type: Thiocyanate Erythromycin, Ultra-clean biodiesel, Research antibodies, Tylosin tartrate - Key Improvement Type: Amino acid raw materials, Feed enzyme preparations, High-quality riboflavin, Arachidonic acid powder - Major Innovation Type: Inactivated vaccine for Porcine Circovirus Type 2, Injectable Epinephrine [3].

Core Insights - The event held on October 15 in Hubei aimed to strengthen collaboration between universities, research institutions, and enterprises in the biomanufacturing sector, establishing a platform for innovation and competitiveness in the industry [1][2] - The event showcased three national-level and ten provincial-level biomanufacturing landmark products, highlighting the advanced technology and economic benefits of these innovations [2] - Hubei University is positioning itself as a leader in synthetic biology in Central China, focusing on breakthroughs in gene editing, enzyme development, and industrial strain design [3][4] Group 1: Event Overview - The event was organized by the Hubei Provincial Department of Economy and Information Technology and included participation from various government officials and industry leaders [1] - Keynote speeches were delivered by prominent scientists and representatives from major companies, emphasizing the importance of biomanufacturing [1] Group 2: Collaboration and Agreements - Hubei University signed multiple cooperation agreements with local governments and enterprises, focusing on technology research and development in areas such as strain modification and enzyme engineering [2] - The event included a signing ceremony for collaborative agreements, indicating strong industry-academia partnerships [2] Group 3: Industry Significance - Biomanufacturing is recognized as a "green engine" for new productive forces and a core area of global technological competition, reshaping industries like pharmaceuticals and food [3] - Hubei's biomanufacturing sector benefits from a multi-dimensional support system, with Hubei University playing a crucial role in advancing life sciences [3][4] Group 4: Achievements and Impact - Hubei University has made significant advancements in technology and innovation, leading multiple national research projects and achieving high rankings in academic performance [4] - The university's contributions have generated substantial economic benefits for the local region, with technology service revenues exceeding 250 million yuan annually [4]

Core Insights - The 2025 China Small and Medium Cities High-Quality Development Index was released, highlighting the achievements of Yishui County in various national rankings [1] - Yishui County has improved its overall strength ranking, moving up 2 places to 85th, and has received three national honors in green development, investment potential, and new urbanization quality [1] Group 1: Industrial Development - Yishui County emphasizes industrial economy as a cornerstone for high-quality development, focusing on biomanufacturing and fine chemicals as key industries [1] - The county has established a "command + chain leader + special team" mechanism to enhance industrial growth, with a total industrial output value of 59.07 billion yuan, reflecting a year-on-year growth of 5.8% [2] Group 2: Urban-Rural Integration - Towns are seen as a bridge for urban-rural integration, with successful examples like Xujiahukou Town leveraging local resources for cultural and economic development [2] - Xujiahukou Town ranked 495th among the national top 1,000 towns, while Yangzhuang Town made its debut on the list at 983rd, showcasing the effectiveness of rural revitalization efforts [2] Group 3: Infrastructure and Public Services - Infrastructure improvements are underway, including transportation and public service upgrades, enhancing the quality of life for residents [3] - Initiatives such as old community renovations and public service enhancements are contributing to a better living environment and community well-being [3] Group 4: Social Development - The county's social development is marked by strong governance and community engagement, with events like the 2025 Shandong (Yishui) Food Expo attracting nearly 400 quality enterprises [3] - Cultural initiatives and community programs are fostering a vibrant social atmosphere, promoting reading and cultural activities [3] Group 5: Future Prospects - Yishui County's comprehensive development strategy positions it favorably in the competitive landscape of county-level governance, contributing to the revitalization of the Yimeng revolutionary area [4] - The county aims to continue enhancing its industrial base, urban-rural integration, and social welfare to achieve sustainable growth [4]

Core Insights - The event "Biomanufacturing Leading the Future" was successfully held in Hefei as part of the 2025 World Manufacturing Conference, attracting over 230 participants from various sectors [1][3] - The focus was on the biomanufacturing industry, discussing key common links and development hotspots, and aiming to create a comprehensive biomanufacturing ecosystem [3][4] Industry Development - Anhui Province has established a comprehensive biomanufacturing industry system covering six sectors: biopharmaceuticals, bio-food, bio-energy, biomaterials, biochemistry, and enzyme preparations [3] - The province has developed three billion-level industry clusters in biopharmaceuticals, bio-food, and bio-energy, with leading companies like Huaheng Bio and Fengyuan Group [3][4] - A 3 billion yuan biomanufacturing industry fund has been established through cooperation between central and local governments [3] Strategic Initiatives - Hefei is integrating biomanufacturing into its new industrial cluster system, forming a dedicated task force and implementing supportive policies [4] - The establishment of the Synthetic Biology Innovation Research Institute and the Hefei (Changfeng) Synthetic Biomanufacturing Industrial Park aims to create a nationally influential biomanufacturing hub [4] Collaborative Efforts - Key projects and funds were signed during the event, including the Synthetic Biology Multiscale Incubation Center and AI-driven biomanufacturing platforms [4] - The establishment of the Anhui Biomanufacturing Industry Alliance will facilitate the gathering of innovative resources and promote the commercialization of research outcomes [7] Future Outlook - Anhui plans to optimize its industrial layout and enhance collaboration among government, industry, academia, research, finance, and services to foster a "four-chain integration" industrial ecosystem [8]